Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Celso Arango

Showing results (121-130 of 570) with videos related to

Pageof 57
Sort By:
Revista De Psiquiatria Y Salud Mental|January 16, 2020
Needs of people with psychosis and their caregivers: «In their own voice»Guillermo Lahera, Jordi Cid, Ana Gonzalez-Pinto, et al.
Neuroscience and Biobehavioral Reviews|June 21, 2015
Inflammation in schizophrenia: A question of balanceJuan C Leza, Borja García-Bueno, Miquel Bioque, et al.
Schizophrenia Bulletin|January 29, 2008
Progression of brain volume changes in adolescent-onset psychosisSantiago Reig, Carmen Moreno, Dolores Moreno, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|December 20, 2005
Neurological soft signs in adolescents with first episode psychosisArantzazu Zabala, Olalla Robles, Mara Parellada, et al.
Schizophrenia Research|December 10, 2019
A longitudinal comparison of two neurocognitive test batteries in patients with schizophrenia and healthy volunteers: Time effects on neuropsychological performance and their relation to functional outcomeElisa Rodriguez-Toscano, Gonzalo López, Maria Mayoral, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 4, 2021
Corrigendum to "Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions. [European Neuropsychopharmacology Volume 48, July 2021, Pages 3-31]"James T McCracken, Evdokia Anagnostou, Celso Arango, et al.
Therapeutic Advances in Psychopharmacology|March 9, 2026
Plain Language Summary of Publication: What experts agree about using long-acting injectable antipsychotic medicine for people early in their experience of schizophreniaAndrea Fagiolini, Murat Yildirim, Celso Arango, et al.
The Lancet. Psychiatry|December 17, 2021
Safety and efficacy of agomelatine in children and adolescents with major depressive disorder receiving psychosocial counselling: a double-blind, randomised, controlled, phase 3 trial in nine countriesCelso Arango, Jan K Buitelaar, Jörg M Fegert, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|January 14, 2023
Pushing forward public mental health agenda and promotion of mental healthDanuta Wasserman, Celso Arango, Andrea Fiorillo, et al.
Child Psychiatry and Human Development|August 1, 2007
Does diagnostic classification of early-onset psychosis change over follow-up?David Fraguas, María J de Castro, Oscar Medina, et al.
Pageof 57

Showing results (121-130 of 570) with videos related to

Sort By:
Pageof 57
Revista De Psiquiatria Y Salud Mental|January 16, 2020
Needs of people with psychosis and their caregivers: «In their own voice»Guillermo Lahera, Jordi Cid, Ana Gonzalez-Pinto, et al.
Neuroscience and Biobehavioral Reviews|June 21, 2015
Inflammation in schizophrenia: A question of balanceJuan C Leza, Borja García-Bueno, Miquel Bioque, et al.
Schizophrenia Bulletin|January 29, 2008
Progression of brain volume changes in adolescent-onset psychosisSantiago Reig, Carmen Moreno, Dolores Moreno, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|December 20, 2005
Neurological soft signs in adolescents with first episode psychosisArantzazu Zabala, Olalla Robles, Mara Parellada, et al.
Schizophrenia Research|December 10, 2019
A longitudinal comparison of two neurocognitive test batteries in patients with schizophrenia and healthy volunteers: Time effects on neuropsychological performance and their relation to functional outcomeElisa Rodriguez-Toscano, Gonzalo López, Maria Mayoral, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 4, 2021
Corrigendum to "Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions. [European Neuropsychopharmacology Volume 48, July 2021, Pages 3-31]"James T McCracken, Evdokia Anagnostou, Celso Arango, et al.
Therapeutic Advances in Psychopharmacology|March 9, 2026
Plain Language Summary of Publication: What experts agree about using long-acting injectable antipsychotic medicine for people early in their experience of schizophreniaAndrea Fagiolini, Murat Yildirim, Celso Arango, et al.
The Lancet. Psychiatry|December 17, 2021
Safety and efficacy of agomelatine in children and adolescents with major depressive disorder receiving psychosocial counselling: a double-blind, randomised, controlled, phase 3 trial in nine countriesCelso Arango, Jan K Buitelaar, Jörg M Fegert, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|January 14, 2023
Pushing forward public mental health agenda and promotion of mental healthDanuta Wasserman, Celso Arango, Andrea Fiorillo, et al.
Child Psychiatry and Human Development|August 1, 2007
Does diagnostic classification of early-onset psychosis change over follow-up?David Fraguas, María J de Castro, Oscar Medina, et al.
Pageof 57